國家衛生研究院 NHRI:Item 3990099045/11788
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 857660      線上人數 : 717
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11788


    題名: Histone demethylase KDM4C is a novel oncogene and prognostic biomarker for prostate cancer
    作者: Chuu, CP;Lin, CY;Wang, BJ;Chen, BC;Tseng, JC
    貢獻者: Institute of Cellular and Systems Medicine
    摘要: Background: Prostate cancer (PCa) is the 5th most common cancer overall in the world. Epigenetic alterations is involved in the development or progression of cancer via regulation of histone modifications. Histone lysine demethylases KDM4C is androgen receptor (AR) co-regulator and modulate AR-mediated transcription. Expression of KDM4C was reported to be higher in castration-resistant prostate cancer (CRPC). Methods: Role of KDM4C in cell proliferation and docetaxel-resistance was determined using MTT assay and 96-well proliferation assay. Effects of KDM4C on PCa migration and invasion was determined by trasnwell assay. Role of KDM4C on cancer stemness was examined using cell sorter. Inhibitory role...
    日期: 2018-10
    關聯: Annals of Oncology. 2018 Oct;29(Suppl. 7):Meeting Abstract O1-19-2.
    Link to: https://doi.org/10.1093/annonc/mdy374.016
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0923-7534&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000459058600058
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85081687045
    顯示於類別:[褚志斌] 會議論文/會議摘要

    文件中的檔案:

    沒有與此文件相關的檔案.



    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋